IPL removes what is inflaming your glands. LLLT works inside the cells that produce your tear film's oil. We use both.

Two treatments, each doing a job the other cannot.

IPL

LLLT

633 nm

400 nm 590 nm 1200 nm

The two are not interchangeable, because they act on different targets. IPL works on the environment around the gland: the abnormal vessels, the inflammatory load, the demodex. LLLT works on the gland cells themselves, on their metabolism and their capacity to secrete. Choosing one means accepting whichever half of the problem it does not reach.

Meibomian gland disease is not one problem. It is four, running at the same time, each one feeding the next. This is why a course of treatment can leave you feeling it nearly worked.

• Inflamed, abnormal vessels along the lid margin Telangiectatic vessels sitting millimetres from your cornea, delivering inflammatory mediators directly onto the ocular surface and keeping the whole cycle running. Closed by IPL
• Demodex and microbial load on the lash line Mites and the bacteria they carry, generating their own inflammation at the base of the lashes and blocking gland openings. Reduced by IPL
• Meibum thickened to the point that it cannot flow Oil that should have the consistency of olive oil behaving more like toothpaste, sitting hard inside the ducts. Softened by both, cleared by expression
• Gland cells that have stopped producing properly After months or years of obstruction and inflammation, the secretory cells themselves are underperforming. This is a functional problem, not a plumbing one, and heat does not fix it. Targeted by LLLT

addressedpartly addressednot addressed

Now leave any one of those out and follow it through.

Settle the inflammation, clear the blockage, but leave your gland cells still struggling, and the cause has been removed while the gland remains unable to do its job. Oil production stays low, your tear film stays unstable, and you come away saying it helped a bit.

Work on the gland cells but leave the inflamed vessels sitting on your lid margin, and production restarts into an environment that will obstruct and inflame it all over again within months.

Do both and skip the clearing, and the softened oil simply stays where it was and hardens again.

There is no version of this where doing part of it is as good as doing all of it. That is the whole case for combining, and it has nothing to do with one machine being better than another. The disease has four moving parts, and no treatment session should end with any of them untouched.

This is where combined IPL and LLLT treatment is at its most useful, and where it is most often missed.

Between 30 and 50 percent of people with rosacea have ocular involvement, and meibomian gland dysfunction is the most common ocular sign. A great many are treated for their skin for years before anyone examines their lid margins, and arrive convinced their eyes are a separate and unrelated problem.

They are the same disease. Rosacea is a disorder of abnormal, inflamed blood vessels, and the vessels along your lid margin behave exactly as the ones across your cheeks do. That is why treatment aimed at one tends to help the other.

• IPL was developed for vascular skin lesions in the first place. In published series it improved facial erythema by around 46 percent and telangiectasia by around 55 percent, with other work reporting substantial clearance of facial rosacea and a marked reduction in flushing.
• In rosacea associated meibomian gland dysfunction specifically, a course of four treatments at three week intervals improved lid parameters and ocular symptoms, and those improvements held at long term follow up.
• Rosacea carries a higher demodex burden on the lash line, and demodex drives its own inflammatory cycle at the lid margin. IPL reduces that load.
• LLLT adds an anti inflammatory effect at the cellular level, downregulating interleukin 1 beta and tumour necrosis factor alpha within the eyelid tissue, without adding any further vascular or thermal load to skin that is already reactive.

If that is you, it means one course of treatment working on the vessels across your face, the vessels on your lid margins, the demodex population and your gland cells at the same time. Very little else in dry eye care does more than one of those at once.

Before treatment begins, you attend a separate full dry eye assessment with meibography, tear film measurements, lipid layer assessment and a validated symptom score. This confirms whether combined IPL and LLLT is appropriate and gives us a baseline to measure against.

Your treatment course then consists of four combined IPL and LLLT sessions. Each session follows the same clinical sequence, with the IPL settings and treatment plan adjusted according to how your eyelids, glands and tear film respond.

1. Eye protection in placeCorneal shields under the lids, or adhesive metal IPL shields over closed eyes, depending on where IPL is being applied.
2. IPL to the treatment area and lid marginEnergy is set according to your Fitzpatrick skin type and reassessed at each visit as the inflammatory vessels recede.
3. LLLT across both lidsEven, comfortable treatment reaches the full length of the upper and lower glands and further softens the meibum that IPL has begun to liquefy.
4. Meibomian gland expression, all four lidsAutoclaved steel paddles apply measured force along each lid to physically clear the softened, stagnant oil from the glands.
5. Reassessment and planHow the glands respond under expression informs the IPL settings, treatment focus and timing of the next session.

Each of the four treatment sessions takes 40 minutes and is delivered by an optometrist from start to finish.

Most people describe IPL as a series of brief, warm flashes against the skin, while LLLT feels like resting under a comfortably warm mask. You can drive yourself home afterwards and return to work the same day.

Because the change is cumulative, and neither therapy does its work in a single visit.

In the published trials, symptoms and tear film stability kept improving with each successive session rather than levelling off after the first, and the measures that matter most had improved significantly by the end of four.

The spacing matters as much as the sessions themselves. Visits sit two to four weeks apart because the treated vessels close and are reabsorbed over weeks rather than hours, the inflammation they were feeding settles gradually, and the gland cells LLLT is working on do not turn over in a day. Treating you weekly would mean applying energy to tissue that has not finished responding to the last visit.

Four is also the point at which we can compare your scans against your baseline and say something honest about whether this is working. Fewer than that and any change you feel could just as easily be the weather, the season or your screen hours that week.

• If your scans show what we want to see at three, we will tell you, and you do not do the fourth
• If four sessions show that light is not the answer for your presentation, that is just as useful to know, and we change direction rather than sell you more of it
• After the initial course, most people need a single maintenance session every six to twelve months

Four is where we start. It is not what you are signed up for.

Comfort does not climb in a straight line, and people reach the same place by quite different routes.

Across the people we treat, four response patterns come up distinctly enough to be worth naming. They are the four routes drawn above.

• Early gain. You feel a difference within days of the first session, and it builds from there.
• Steady climb. Nothing dramatic at any single visit, but each session leaves you a little better than the last.
• Late gain. Very little changes through the first two sessions, then it arrives at the third and fourth. This is the group most likely to give up one session too early.
• Slower start. Comfort dips below where you began before it turns, usually within the first week or two.

Taken overall, in the order of 90% of people fall into one of those four and gain meaningful comfort from a course. Around 10% see no change across all four sessions. We would rather you knew that at the start than discovered it at the end, and it is part of why we measure rather than rely on how a session felt.

The slower start is the one worth explaining, because it is the most unsettling to live through. It is not the treatment failing. As the inflammation comes down and the surface begins to settle, corneal nerves that had been dulled by chronic dryness start working properly again, and for a short period you are simply more aware of sensation than you were. It settles as things normalise.

We tell you all of this before you start for one reason. If nobody warns you, a rough patch after session two reads as proof it is not working, and people stop right before the turn.

Your baseline scans are repeated one month after the start-up protocol, so whatever you happened to be feeling in any given week, we can both look at whether your glands and tear film have actually changed.

Pairing IPL or another pulsed-light treatment with an LLLT mask is not unusual in itself. Some packages offered elsewhere use a polychromatic light source marketed as OPE together with a light therapy mask, delivered in a short and fixed appointment.

So the question is not whether the therapies are combined. It is what is being combined, where it is applied, and what happens around it.

• The IPL technology itself. OptiLight is the only device of its kind with FDA authorisation for dry eye. Other IPL systems, such as OPE, may hold CE marking in Europe but do not have FDA authorisation for dry eye. As OPE uses a different emission technology, the trial evidence behind OptiLight's authorisation does not carry across to it.
• Where IPL is applied. We treat the upper and lower lids and deliver IPL at the lid margin behind appropriate eye protection. Protocols confined to the cheek and below the eye leave the lid that carries the greater number of glands untreated.
• What follows IPL. Every session here ends with expression of all four lids. IPL that softens meibum without anyone clearing it afterwards leaves the blockage where it was.
• Who is holding the handpiece. An optometrist, for the whole session, not a technician working through a set protocol on a timer.
• Whether anyone can tell it worked. Baseline scans repeated through the course, so improvement is demonstrated rather than assumed.

Two clinics can both describe what they offer as combined IPL and LLLT treatment for dry eye and be doing substantially different things. The device, the lids, the clearing step and the measurement are what separate them.